These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38992452)

  • 1. Mechanistic insights into carvedilol's potential protection against doxorubicin-induced cardiotoxicity.
    Elmorsy EA; Saber S; Hamad RS; Abdel-Reheim MA; El-Kott AF; AlShehri MA; Morsy K; Negm S; Youssef ME
    Eur J Pharm Sci; 2024 Sep; 200():106849. PubMed ID: 38992452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of doxorubicin-induced Cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial).
    Carrasco R; Ramirez MC; Nes K; Schuster A; Aguayo R; Morales M; Ramos C; Hasson D; Sotomayor CG; Henriquez P; Cortés I; Erazo M; Salas C; Gormaz JG
    Trials; 2020 Feb; 21(1):137. PubMed ID: 32019575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
    Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
    Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
    Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
    J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
    Oliveira PJ; Bjork JA; Santos MS; Leino RL; Froberg MK; Moreno AJ; Wallace KB
    Toxicol Appl Pharmacol; 2004 Oct; 200(2):159-68. PubMed ID: 15476868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis.
    Shaker RA; Abboud SH; Assad HC; Hadi N
    BMC Pharmacol Toxicol; 2018 Jan; 19(1):3. PubMed ID: 29321061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
    Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management.
    Rawat PS; Jaiswal A; Khurana A; Bhatti JS; Navik U
    Biomed Pharmacother; 2021 Jul; 139():111708. PubMed ID: 34243633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity.
    Wu YP; Zhang S; Xin YF; Gu LQ; Xu XZ; Zhang CD; You ZQ
    Phytomedicine; 2021 Jul; 88():153597. PubMed ID: 34111614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
    Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
    Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3'-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis.
    Hajra S; Basu A; Singha Roy S; Patra AR; Bhattacharya S
    Free Radic Res; 2017 Oct; 51(9-10):812-827. PubMed ID: 28922986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition.
    Yousefian M; Hosseinzadeh H; Hayes AW; Hadizadeh F; Karimi G
    J Pharm Pharmacol; 2022 Mar; 74(3):351-359. PubMed ID: 34562089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of doxorubicin (DOX)-induced genotoxicity and cardiotoxicity: Effect of plant derived small molecule indole-3-carbinol (I3C) on oxidative stress and inflammation.
    Hajra S; Patra AR; Basu A; Bhattacharya S
    Biomed Pharmacother; 2018 May; 101():228-243. PubMed ID: 29494960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lack of Synergy between Carvedilol and the Preventive Effect of Dexrazoxane in the Model of Chronic Anthracycline-Induced Cardiomyopathy.
    Szponar J; Ciechanski E; Ostrowska-Lesko M; Gorska A; Tchorz M; Dabrowska A; Dudka J; Murias M; Kowalczyk M; Korga-Plewko A; Mandziuk S
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats.
    Kim YH; Park SM; Kim M; Kim SH; Lim SY; Ahn JC; Song WH; Shim WJ
    Toxicol Mech Methods; 2012 Jul; 22(6):488-98. PubMed ID: 22455613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research progress on the role and mechanism of Sirtuin family in doxorubicin cardiotoxicity.
    Zhang X; Huang C; Hou Y; Jiang S; Zhang Y; Wang S; Chen J; Lai J; Wu L; Duan H; He S; Liu X; Yu S; Cai Y
    Phytomedicine; 2024 Jul; 129():155673. PubMed ID: 38677274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.